AtriCure, Inc.
General ticker "ATRC" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.6B (TTM average)
AtriCure, Inc. follows the US Stock Market performance with the rate: 39.4%.
Estimated limits based on current volatility of 5.8%: low 36.78$, high 41.28$
Factors to consider:
- Total employees count: 1300 as of 2024
- US accounted for 26.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Market acceptance, Market competition, Clinical trial uncertainties, Manufacturing disruptions, Operational and conduct risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [25.19$, 40.75$]
- 2025-12-31 to 2026-12-31 estimated range: [26.86$, 43.25$]
Financial Metrics affecting the ATRC estimates:
- Negative: with PPE of -45.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 2.11 > -0.62
- Positive: Shareholder equity ratio, % of 75.65 > 64.17
- Positive: -9.48 < Industry operating profit margin (median), % of -6.69
- Positive: -0.04 < Industry operating cash flow per share per price (median), % of 1.00
- Negative: negative Net income
- Positive: 0.04 < Operating cash flow per share per price, % of 0.85
Short-term ATRC quotes
Long-term ATRC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $330.38MM | $399.25MM | $465.31MM |
| Operating Expenses | $373.05MM | $425.93MM | $505.32MM |
| Operating Income | $-42.67MM | $-26.68MM | $-40.01MM |
| Non-Operating Income | $-3.53MM | $-3.16MM | $-3.66MM |
| Interest Expense | $4.99MM | $6.92MM | $6.41MM |
| R&D Expense | $57.34MM | $73.92MM | $96.18MM |
| Income(Loss) | $-46.20MM | $-29.85MM | $-43.67MM |
| Taxes | $0.27MM | $0.59MM | $1.02MM |
| Profit(Loss)* | $-46.47MM | $-30.44MM | $-89.40MM |
| Stockholders Equity | $456.75MM | $466.17MM | $460.97MM |
| Inventory | $45.93MM | $67.90MM | $75.33MM |
| Assets | $585.45MM | $613.93MM | $609.33MM |
| Operating Cash Flow | $-22.14MM | $4.48MM | $12.20MM |
| Capital expenditure | $16.88MM | $42.00MM | $23.46MM |
| Investing Cash Flow | $44.01MM | $21.82MM | $30.23MM |
| Financing Cash Flow | $-7.06MM | $-0.03MM | $-3.60MM |
| Earnings Per Share** | $-1.02 | $-0.66 | $-1.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.